Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-14-0701
Full Text
Open PDFAbstract
Available in full text
Date
January 22, 2015
Authors
Publisher
American Association for Cancer Research (AACR)